Overview

Study of Mitomycin-C Application in Laryngotracheal Stenosis

Status:
Terminated
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
This is a randomized, prospective, double-blind, placebo-controlled clinical trial of the use of mitomycin-C topical application as an adjunctive treatment in the endoscopic surgical treatment of patients with laryngotracheal stenosis. We hypothesize that the use of mitomycin-C improves patient outcome in the endoscopic surgical treatment of laryngotracheal stenosis.
Phase:
N/A
Details
Lead Sponsor:
University of California, San Francisco
Treatments:
Mitomycin
Mitomycins